Second Sight Medical Products (NASDAQ:EYES)
Industry: Healthcare

Second Sight Medical Products, Inc. develops, manufactures, and markets prosthetic devices to restore functional vision to blind individuals in the United States, Italy, Germany, France, Canada, and Singapore. The company's product is the Argus II System, which treats outer retinal degenerations, such as retinitis pigmentosa. The company was formerly known as Second Sight LLC. and changed its name to Second Sight Medical Products, Inc. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, California.

Current Quote*
Last: $1.960
Change: 0.030
Book: $13.333
Volume: 507,622

As Of: 03/22 16:21 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol EYES

  • No BuyIns.Net Alerts Available for EYES

Graphs for EYES

3 Month Graph

6 Month Graph

1 Year Graph